Clicky

Kintara Therapeutics, Inc.(KTRA)

Description: Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs.


Keywords: Pharmaceutical Life Sciences Cancer Therapies Novel Cancer Enzon Pharmaceuticals

Home Page: www.kintara.com

KTRA Technical Analysis

9920 Pacific Heights Blvd
San Diego, CA 92121
United States
Phone: 858 350 4364


Officers

Name Title
Mr. Robert E. Hoffman B.B.A., CPA, CPA Pres, CEO & Chairman
Dr. Dennis M. Brown B.Sc., M.A., Ph.D. Co-Founder & Chief Scientific Officer
Mr. Scott Praill B.Sc., C.P.A., CA, CPA, BSc CFO & Sec.
Mr. Jeffrey A. Bacha B.Sc., M.B.A. Founder
Mr. Greg A. Johnson Acting Head of Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 7.8075
Price-to-Sales TTM: 0
IPO Date: 2013-02-22
Fiscal Year End: June
Full Time Employees: 3
Back to stocks